HbA1c: A Review of Analytical and Clinical Aspects
2
조회
0
다운로드
16
인용
0
참고문헌
키워드
초록
After the relationship between glycemic control and the HbA1c concentration was demonstrated, many tests have been developed to determine the HbA1c concentration. The test results are standardized to the International Federation of Clinical Chemistry (IFCC) Reference Measurement Procedure (RMP) in harmony with the efforts of the National Glycohemoglobin Standardization Program (NGSP). The longitudinal use of the test requires strict quality management including accreditation of the laboratory, a dedicated internal control design, participation in an external quality assessment (EQA) program (proficiency test), and careful consideration of pre- and post-analytical aspects of the test. Performance goals for optimizing determination of the HbA1c concentration have been described. As an index of long-term glycemic control and a risk predictor, the HbA1c concentration is an indispensable part of routine management of diabetes. Because of the improving quality of the test, the HbA1c concentration is being increasingly applied in the diagnosis of diabetes. There are, however, concerns of this application in point-of-care settings. The HbA1c concentration is also used to achieve stringent control in pregnant diabetic patients. Strict standardization enables the definition of universal reference values and clinical decision limits. This review describes the present status of analytical and clinical aspects of determining the HbA1c concentration and highlights the challenges involved.
Abstract
After the relationship between glycemic control and the HbA1c concentration was demonstrated, many tests have been developed to determine the HbA1c concentration. The test results are standardized to the International Federation of Clinical Chemistry (IFCC) Reference Measurement Procedure (RMP) in harmony with the efforts of the National Glycohemoglobin Standardization Program (NGSP). The longitudinal use of the test requires strict quality management including accreditation of the laboratory, a dedicated internal control design, participation in an external quality assessment (EQA) program (proficiency test), and careful consideration of pre- and post-analytical aspects of the test. Performance goals for optimizing determination of the HbA1c concentration have been described. As an index of long-term glycemic control and a risk predictor, the HbA1c concentration is an indispensable part of routine management of diabetes. Because of the improving quality of the test, the HbA1c concentration is being increasingly applied in the diagnosis of diabetes. There are, however, concerns of this application in point-of-care settings. The HbA1c concentration is also used to achieve stringent control in pregnant diabetic patients. Strict standardization enables the definition of universal reference values and clinical decision limits. This review describes the present status of analytical and clinical aspects of determining the HbA1c concentration and highlights the challenges involved.
참고문헌 (35)
- "WHO diabetes media centre"[URL]
- American Diabetes Association, "Economic costs of diabetes in the U.S. In 2007", Diabetes Care, 31, pp.596~615 (2008)
- "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus", N Eng J Med, 329, pp.977~986 (1993), The Diabetes Control and Complications Trial Research Group
- "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", Lancet, 352, pp.837~853 (1998), UK Prospective Diabetes Study (UKPDS) Group
- White NH, "Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT", EDIC: comparison of adults and adolescents, 2010, pp.59, 1244~1253
- Weykamp C, "A review of the challenge in measuring hemoglobin A1c", J Diabetes Sci Technol, 3, pp.439~445 (2009)
- Jeppsson JO, "Approved IFCC reference method for the measurement of HbA1c in human blood", Clin Chem Lab Med, 40, pp.78~89 (2002)
- Hoelzel W, "IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study", Clin Chem, 50, pp.166~174 (2004)
- Jaisson S, "First evaluation of Capillarys 2 Flex Piercing (Sebia)® as a new analyzer for HbA1c assay by capillary electrophoresis", Clin Chem Lab Med, 50, pp.1769~1775 (2012)
- Mallia AK, "Preparation and use of a boronic acid support for separation and quantitation of glycosylated hemoglobins", Anal Lett, 14, pp.649~661 (1981)
- John WG, "Enzyme immunoassay--a new technique for estimating haemoglobin A1c", Clin Chem, 39, pp.663~666 (1993)
- Liu L, "Direct enzymatic assay for % HbA1c in human whole blood samples", Clin Biochem, 41, pp.576~583 (2008)
- Weykamp CW, "Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods", Clin Chem, 39, pp.1717~1723 (1993)
- Little RR, "The long and winding road to optimal HbA1c measurement", Clin Chim Acta, 418, pp.63~71 (2013)
- "HbA1c assay interferences"[URL]
- Greg Miller W, "Roadmap for Harmonization of clinical laboratory measurement procedures", Clin Chem, 57, pp.1108~1117 (2011)
- Little RR, "The national glycohemoglobin standardization program: a five-year report", Clin Chem, 47, pp.1985~1992 (2001)
- Shima K, "Interlaboratory differences in GHb measurement in Japan: the fifth report of the GHb standardization committee, the Japan Diabetes Society", J Jap Diabetes Soc, 41, pp.317~323 (1998)
- Jeppsson JO, "Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated", Clin Chem, 32, pp.1867~1872 (1986)
- Weykamp C, "The IFCC Reference Measurement System for HbA1c: a 6-year progress report", Clin Chem, 54, pp.240~248 (2008)
- Sacks DB, "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", Clin Chem, 57, pp.e1~e47 (2011)
- Consensus Committee, "Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation", Diabetes Care, 30, pp.2399~2400 (2007)
- Little RR, "Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods", Diabetes Technol Ther, 9, pp.36~42 (2007)
- Little RR, "Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care", Clin Chem, 57, pp.205~214 (2011)
- Weykamp CW, "The analytical goals for hemoglobin A(1c) measurement in IFCC units and National Glycohemoglobin Standardization Program Units are different", Clin Chem, 57, pp.1204~1206 (2011)
- American Diabetes Association, "Standards of medical care in diabetes-2011", Diabetes Care, 34(S1), pp.S11~S61 (2011)
- American Diabetes Association, "Standards of medical care in diabetes-2010", Diabetes Care, 33(S1), pp.S11~S61 (2010)
- John WG, "Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011", Diabet Med, 29, pp.1350~1357 (2012)
- Seino Y, "Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus", J Diabetes Invest, 1, pp.212~228 (2010)
- "Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus"[URL]
- Kitzmiller JL, "Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care", Diabetes Care, 31, pp.1060~1079 (2008)
- Davidson MB, "Diabetes research and diabetes care", Where do we stand? Diabetes Care, 21, pp.2152~2160 (1998)
- Larsen ML, "Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus", N Engl J Med, 323, pp.1021~1025 (1990)
- Ziemer DC, "Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies", Ann Intern Med, 152, pp.770~777 (2010)
- Lenters-Westra E, "Six of eight haemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria", Clin Chem, 56, pp.44~52 (2010)